申请人:LIFE TECHNOLOGIES CORPORATION
公开号:US10179143B2
公开(公告)日:2019-01-15
Methods of using azide-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to inhibit infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. Also, provided are methods of tracking a virus in vivo, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The azide-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.
提供了使用叠氮修饰的生物大分子(如脂肪酸、碳水化合物和脂质)治疗感染病毒的植物、昆虫或动物或抑制病毒(如人类免疫缺陷病毒)感染性的方法。还提供了用叠氮修饰的生物大分子(如脂肪酸、碳水化合物或异戊烯类脂质)标记病毒(如人类免疫缺陷病毒)的方法。此外,还提供了利用叠氮修饰的生物大分子(如脂肪酸、碳水化合物或异戊烯类脂质)在体内追踪病毒的方法。叠氮修饰的生物大分子可与药学上可接受的赋形剂结合,制成药物组合物,其中可选择含有另一种抗病毒剂和/或递送剂,如脂质体。